Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details Narrative)

v3.19.3
Commitments and Contingencies (Details Narrative)
1 Months Ended 3 Months Ended 12 Months Ended 36 Months Ended
Sep. 26, 2019
USD ($)
Sep. 13, 2018
USD ($)
Sep. 13, 2018
EUR (€)
Aug. 12, 2016
USD ($)
May 05, 2016
USD ($)
May 05, 2016
AUD ($)
Jun. 30, 2012
Sep. 30, 2019
USD ($)
shares
Jun. 30, 2018
USD ($)
Jun. 30, 2018
USD ($)
Dec. 31, 2014
USD ($)
Jun. 30, 2019
Penalty amount                     $ 30,000  
Operating lease term                       5 years
Royalties percentage   2.00% 2.00%                  
Royalty Agreement Terms [Member]                        
Operating leases income statement revenue percentage             2.00%          
License Agreement Terms [Member]                        
Operating leases income statement revenue percentage             5.00%          
New Five-Year Operating Lease Agreement [Member]                        
Payments for rent         $ 2,472              
New Five-Year Operating Lease Agreement [Member] | AUD Currency [Member]                        
Payments for rent           $ 3,606            
Manufacturing Services Agreement [Member] | Minimum [Member]                        
Anticipated milestone payment       $ 2,500,000                
Manufacturing Services Agreement [Member] | Maximum [Member]                        
Anticipated milestone payment       $ 5,000,000                
Amatsigroup Agreement [Member]                        
Payments description       The Company anticipates that its payments to Amatsigroup under the MSA will range between $2.5 million and $5.0 million over three years, when the finished drug product is manufactured and released for clinical trials. The Company has spent a total of $1,689,146 of costs to date under this contract of which $1,689,146 was expensed in prior years. The MSA shall continue for a term of three years unless extended by mutual agreement in writing.                
Contract cost               $ 1,689,146   $ 1,689,146    
One-Year Collaboration Agreement [Member]                        
Payment for services   $ 59,508                    
One-Year Collaboration Agreement [Member] | Euros [Member]                        
Payment for services | €     € 52,000                  
Two-Year Collaboration Agreement [Member]                        
Payment for services   $ 45,775                    
Two-Year Collaboration Agreement [Member] | Euros [Member]                        
Payment for services | €     € 40,000                  
From 2012 through the 2014 [Member]                        
Penalty amount                 $ 10,000      
Regal Consulting, LLC [Member]                        
Loss contingency amount               $ 400,000        
Number of shares issued for services | shares               60,000        
Foley Shechter [Member]                        
Legal fees $ 150,000